Treatment of Acute Bacterial Sinusitis
Amoxicillin 500 mg twice daily for 10-14 days is the first-line treatment for most adults with acute bacterial sinusitis, with treatment continuing until symptom-free for 7 days. 1
Confirming the Diagnosis Before Treatment
Before initiating antibiotics, ensure the diagnosis meets criteria for acute bacterial sinusitis—not just viral rhinosinusitis 2:
- Persistent symptoms ≥10 days without improvement (nasal discharge, congestion, facial pain/pressure, or cough) 1, 2
- Severe symptoms for ≥3 consecutive days (fever >39°C with purulent nasal discharge and facial pain) 1, 2
- "Double sickening" pattern: initial improvement from viral URI followed by worsening symptoms 1, 2
Most cases of acute rhinosinusitis are viral and resolve within 7 days without antibiotics 2. Overdiagnosis leads to unnecessary antibiotic use and resistance 2.
First-Line Antibiotic Selection
Standard Therapy (Uncomplicated Cases)
- Amoxicillin 500 mg twice daily for mild disease without recent antibiotic exposure 1, 2
- Amoxicillin 875 mg twice daily for moderate severity or areas with resistant S. pneumoniae 1, 2
- Duration: 10-14 days or until symptom-free for 7 days 1, 2
High-Risk or Severe Cases
Amoxicillin-clavulanate 875 mg/125 mg twice daily is preferred for 1, 2:
- Recent antibiotic use within 4-6 weeks
- Severe symptoms at presentation
- Age <2 years or >65 years
- Daycare attendance (children)
- Areas with high prevalence of β-lactamase-producing organisms
The clavulanate component provides essential coverage against β-lactamase-producing H. influenzae and M. catarrhalis, which have become increasingly prevalent 1.
Penicillin-Allergic Patients
Second- or third-generation cephalosporins are the preferred alternatives due to negligible cross-reactivity risk 1, 2:
- Cefuroxime-axetil (second-generation): standard alternative 1, 2
- Cefpodoxime-proxetil (third-generation): superior activity against H. influenzae 1, 2
- Cefdinir (third-generation): excellent coverage 1, 2
For severe β-lactam allergy, use respiratory fluoroquinolones 1:
Critical caveat: Azithromycin and other macrolides should NOT be used due to 20-25% resistance rates in S. pneumoniae and H. influenzae 1. Doxycycline has 20-25% predicted bacteriologic failure and limited activity against H. influenzae 1.
Treatment Failure Protocol
If no improvement after 3-5 days, reassess and switch antibiotics 1, 2:
- Switch to amoxicillin-clavulanate 875 mg/125 mg twice daily if started on plain amoxicillin 1, 2
- Switch to respiratory fluoroquinolone (levofloxacin or moxifloxacin) if already on amoxicillin-clavulanate 1
- Consider imaging (CT sinuses) to confirm diagnosis and rule out complications 1
Fluoroquinolones provide 90-92% predicted clinical efficacy and excellent coverage against multi-drug resistant S. pneumoniae 1.
Anatomic Location Considerations
- Maxillary sinusitis (most common): standard first-line antibiotics as above 1
- Frontal, ethmoidal, or sphenoidal sinusitis: consider starting with fluoroquinolones due to risk of serious complications (orbital cellulitis, meningitis, brain abscess) 1, 2
Adjunctive Therapies (Always Recommended)
Intranasal corticosteroids are the cornerstone adjunct 1, 2:
- Reduce inflammation and mucosal edema
- Improve sinus drainage
- May decrease need for antibiotics
- Continue throughout antibiotic course
- Saline nasal irrigation (hypertonic preferred for better mucociliary clearance) 3
- Analgesics (acetaminophen or NSAIDs) for pain 1
- Adequate hydration 1
- Warm facial packs 1
- Sleep with head elevated 1
Oral decongestants (pseudoephedrine) or topical decongestants (oxymetazoline) may provide symptomatic relief 2:
- Limit topical decongestants to ≤5 days to avoid rebound congestion (rhinitis medicamentosa) 2
Short-term oral corticosteroids (e.g., prednisone 40-60 mg daily for 5 days) may be reasonable for 1, 2:
- Marked mucosal edema
- Failure to respond to initial antibiotic treatment
- Nasal polyposis
- Severe pain (acute hyperalgic sinusitis)
Pediatric Dosing
- Standard therapy: Amoxicillin 45 mg/kg/day divided twice daily 1
- High-dose therapy (areas with resistant S. pneumoniae or risk factors): Amoxicillin 80-90 mg/kg/day divided twice daily 1, 2
- High-dose amoxicillin-clavulanate: 80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate divided twice daily 1, 2
- Duration: 10-14 days 1
- Reassess at 72 hours if no improvement 1
Watchful Waiting Option
For uncomplicated acute bacterial sinusitis in adults with reliable follow-up, watchful waiting without immediate antibiotics is appropriate 1:
- Start antibiotics if no improvement by 7 days or worsening at any time 1
- Number needed to treat with antibiotics is 3-5 for persistent symptoms 1
Critical Pitfalls to Avoid
- Do not use azithromycin as first-line therapy—resistance rates are 20-25% 1
- Do not use fluoroquinolones routinely—reserve for treatment failures, severe disease, or complicated sinusitis to prevent resistance 1, 2
- Do not use topical decongestants >5 days—causes rebound congestion 2
- Complete the full antibiotic course even after symptom improvement to prevent relapse and resistance 1, 4
- Reassess at 3-5 days if no improvement—early recognition of treatment failure prevents complications 1, 2
- Take amoxicillin-clavulanate with food to reduce gastrointestinal upset 4
When to Refer to Specialist
Refer to otolaryngology or allergy/immunology for 1, 3:
- Sinusitis refractory to appropriate antibiotic treatment
- Recurrent sinusitis (≥3 episodes per year)
- Suspected complications (orbital cellulitis, meningitis, abscess)
- Need to clarify allergic or immunologic basis
- Consideration for endoscopic sinus surgery